You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Safty

Showing 1 - 25 of 90
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronary Artery Disease Trial (Lansoprazole 15 mg)

Not yet recruiting
  • Coronary Artery Disease
  • Lansoprazole 15 mg
  • (no location specified)
Apr 6, 2023

Cervical Intraepithelial Neoplasia, Cervical Cancer, Condylomata Acuminata Trial in Nanjing, Chengdu (Nonavalent HPV vaccine,

Active, not recruiting
  • Cervical Intraepithelial Neoplasia
  • +2 more
  • Nonavalent HPV vaccine
  • Bivalent HPV vaccine
  • Nanjing, Jiangsu, China
  • +1 more
Feb 10, 2022

HPV Infection Vaccine Safety SCT1000 Trial in Nanjing (SCT1000, Gardasil®9, )

Recruiting
  • HPV Infection Vaccine Safety SCT1000
  • Nanjing, Jiangsu, China
    Guanyun Country CDC
Sep 14, 2021

Efficacy and Safty of Camrelizumab Plus S-1 Maintenance After First-line Induction Chemo for GC Trial in Beijing

Recruiting
  • Efficacy and Safty of Camrelizumab Plus S-1 Maintenance After First-line Induction Chemotherapy for GC
  • Beijing, Beijing, China
    Lin Zhao
Dec 24, 2021

NSCLC, Small Cell Lung Cancer, Pancreas Cancer Trial in Shanghai (Infusion of iNKT cells and CD8+T cells)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • +5 more
  • Infusion of iNKT cells and CD8+T cells
  • Shanghai, Shanghai, China
    Shanghai Public Health Clinical Center
May 6, 2022

Juxtarenal Abdominal Aortic Aneurysm Trial in Beijing (WeFlow-JAAA Stent Graft System)

Recruiting
  • Juxtarenal Abdominal Aortic Aneurysm
  • WeFlow-JAAA Stent Graft System
  • Beijing, China
    The General Hospital of the People's Liberation Army
Mar 1, 2022

Interventional, Prevention, Randomized Trial in Nanjing (SCT1000, Gardasil®9, Gardasil®)

Recruiting
  • Interventional
  • +2 more
  • SCT1000
  • +3 more
  • Nanjing, Jiangsu, China
    Guanyun Country CDC
Oct 21, 2021

Anemia in Incident Dialysis Patients Trial in Changsha (HIF-PHI, Epoetin Alfa)

Not yet recruiting
  • Anemia in Incident Dialysis Patients
  • Changsha, Hunan, China
    Department of Nephrology, Second Xiangya Hospital, Central South
May 20, 2021

Degenerative Arthritis, Knee Osteoarthritis Trial in Korea, Republic of (JOINTSTEM, saline)

Completed
  • Degenerative Arthritis
  • Knee Osteoarthritis
  • Cheongju-si, Korea, Republic of
  • +11 more
Jan 28, 2021

Efficacy, Safty, Device Trial in Shanghai (percutaneous ventricular restoration using heartech® device)

Unknown status
  • Efficacy, Safty, Device
  • percutaneous ventricular restoration using heartech® device
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Jan 9, 2020

B-cell Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab, Conventional therapy)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Suzhou, Jiangsu, China
    The first affiliated hospital of Soochow University
Sep 26, 2022

Myopia Trial in Guangzhou (CARE1.02, Single-vision spectacle lens)

Not yet recruiting
  • Myopia
  • CARE1.02
  • Single-vision spectacle lens
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Apr 17, 2023

Real World Study of Linperlisib for Lymphoma Treatment

Not yet recruiting
  • Focus on the Lymphoma Including B/T-cell Lymphoma
  • Shanghai, China
  • +1 more
May 9, 2023

Lung Cancer Trial (Centipeda minima+PD-1/PD-L1 inhibitor, PD-1/PD-L1 inhibitor)

Not yet recruiting
  • Lung Cancer
  • Centipeda minima+PD-1/PD-L1 inhibitor
  • PD-1/PD-L1 inhibitor
  • (no location specified)
Feb 17, 2023

Williams Syndrome Trial in Ramat-Gan, Tel Aviv (Open Label Clemastine with a blinded randomize withdrawal)

Recruiting
  • Williams Syndrome
  • Open Label Clemastine with a blinded randomize withdrawal
  • Ramat-Gan, Israel
  • +1 more
Oct 11, 2023

Advanced Solid Tumors, Advanced Esophagus Cancer and Squamous Cell Carcinoma of the Esophageal Junction Trial in Guangzhou

Recruiting
  • Advanced Solid Tumors
  • CYH33 for tablet
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jan 4, 2023

Recurrent or Metastatic Bladder Cancer Trial in Shanghai (Chimeric exosomal tumor vaccines)

Recruiting
  • Recurrent or Metastatic Bladder Cancer
  • Chimeric exosomal tumor vaccines
  • Shanghai, China
    Fudan University Pudong Medical Center
Sep 26, 2022

Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in Changsha, Suzhou (U16)

Recruiting
  • Relapsed or Refractory Non-Hodgkin's Lymphoma
  • Changsha, Hunan, China
  • +1 more
Mar 13, 2023

Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab vedotin and Rituximab)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib, Polatuzumab vedotin and Rituximab
  • Shanghai, Shanghai, China
    Zhongshan Hospital，Fudan University
Jul 10, 2023

Solid Tumor Trial in Wuhan (Neo-T, Cyclophosphamide, Fludarabine)

Recruiting
  • Solid Tumor
  • Neo-T
  • +3 more
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Mar 23, 2023

Asthma Trial in China (Methacholine Chloride)

Not yet recruiting
  • Asthma
  • Methacholine Chloride
  • Beijing, Beijing, China
  • +11 more
Dec 1, 2022

Myopia Trial in Guangzhou (New defocus spectacle lenses, Convenional aspheric single-vision spectacle lenses)

Not yet recruiting
  • Myopia
  • New defocus spectacle lenses
  • Convenional aspheric single-vision spectacle lenses
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Feb 13, 2023

Leptomeningeal Metastasis, Immune Checkpoint Inhibitor, Endostatin Trial in Hebei (Camrelizumab or envafolimab)

Recruiting
  • Leptomeningeal Metastasis
  • +2 more
  • Camrelizumab or envafolimab
  • Hebei, China
    The Second Hospital of Hebei Medical University
May 19, 2022

Alopecia Areata Trial (Jaktinib)

Not yet recruiting
  • Alopecia Areata
  • (no location specified)
Feb 22, 2022

Myopia Trial in Guangzhou (Partition defocus myopia management spectacle lens, Spectacle lenses with aspherical lenslets)

Not yet recruiting
  • Myopia
  • Partition defocus myopia management spectacle lens
  • Spectacle lenses with aspherical lenslets
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Feb 13, 2023